Balanced news tone
News Sentiment
600056 sentiment intelligence
China Meheco Group Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
80/100 classification confidence.
directly relevant articles
high-authority source matches
+4.1% over one week, +5.0% over four weeks, trend inactive, and near fair-value range.
China National Pharmaceutical Group Co., Ltd. (SHA: 600056) announced that its subsidiary's marketing application for the chemical active pharmaceutical ingredient ezetimibe has been approved.
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
China National Pharmaceutical Group Co., Ltd. (SHA: 600056) announced that its subsidiary's marketing application for the chemical active pharmaceutical ingredient ezetimibe has been approved.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 11:54
- Source
- 富途牛牛
Price to book forward of China Meheco Group Co., Ltd. Class A – SSE:600056
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 14:27
- Source
- TradingView
Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Dec 2025 08:00
- Source
- Market source
A Stock Trader’s Guide To China’s Potential Exit From Covid Zero
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 05 Nov 2022 07:00
- Source
- NDTV Profit